Option Care Health, Inc.: Form 10-Q for the period ended Mar 31, 2023
Filed with the SEC on May 4, 2023 and accepted by EDGAR at May 4, 2023, 17:00 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-01-01 to 2023-03-31 | $1.02bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-01-01 to 2023-03-31 | $786.8m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2023-01-01 to 2023-03-31 | $229.0m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2023-01-01 to 2023-03-31 | $147.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-01-01 to 2023-03-31 | $66.6m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-01-01 to 2023-03-31 | $13.8m | us-gaap:InterestExpense |
| Income tax | 3 months2023-01-01 to 2023-03-31 | $15.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-01-01 to 2023-03-31 | $39.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-01-01 to 2023-03-31 | $0.21 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-01-01 to 2023-03-31 | $0.22 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-01-01 to 2023-03-31 | 182,735,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2023-01-01 to 2023-03-31 | $89.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2023-01-01 to 2023-03-31 | $5.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 3 months2023-01-01 to 2023-03-31 | $75.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-03-31 | $297.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-03-31 | $1.03bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-03-31 | $3.13bn | us-gaap:Assets |
| Current liabilities | At period end2023-03-31 | $618.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-03-31 | $1.78bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-03-31 | $1.06bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2023-03-31 | $6.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2023-03-31 | $1.35bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001014739-23-000019. Last ingested by Listed: Oct 27, 2026, 16:18 ET. Listed shows no prices and gives no investment advice.